Literature DB >> 2546774

Testing of organisms for susceptibility to triazoles: is it justified?

G S Kobayashi1, E D Spitzer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546774     DOI: 10.1007/BF01964051

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  13 in total

1.  Isolation and analysis of ketoconazole resistant mutants of Saccharomyces cerevisiae.

Authors:  P F Watson; M E Rose; S L Kelly
Journal:  J Med Vet Mycol       Date:  1988-06

2.  Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods.

Authors:  J N Galgiani; J Reiser; C Brass; A Espinel-Ingroff; M A Gordon; T M Kerkering
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

3.  Broth dilution testing of Candida albicans susceptibility to ketoconazole.

Authors:  C E Hughes; R L Bennett; W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 4.  Antifungal susceptibility tests.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

5.  Heterogeneity of action of mechanisms among antimycotic imidazoles.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

6.  Azole resistance in Candida albicans.

Authors:  J F Ryley; R G Wilson; K J Barrett-Bee
Journal:  Sabouraudia       Date:  1984

7.  Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole.

Authors:  C A Hitchcock; K J Barrett-Bee; N J Russell
Journal:  J Med Vet Mycol       Date:  1987-10

8.  Multicenter evaluation of four methods of yeast inoculum preparation.

Authors:  M A Pfaller; L Burmeister; M S Bartlett; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

9.  Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole.

Authors:  S Shadomy; S C White; H P Yu; W E Dismukes
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

Review 10.  Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action.

Authors:  H Vanden Bossche
Journal:  Curr Top Med Mycol       Date:  1985
View more
  15 in total

1.  Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.

Authors:  A Espinel-Ingroff; C W Kish; T M Kerkering; R A Fromtling; K Bartizal; J N Galgiani; K Villareal; M A Pfaller; T Gerarden; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

3.  Standardized susceptibility testing of fluconazole: an international collaborative study.

Authors:  M A Pfaller; B Dupont; G S Kobayashi; J Müller; M G Rinaldi; A Espinel-Ingroff; S Shadomy; P F Troke; T J Walsh; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

4.  Susceptibility of clinical isolates of fungi to saperconazole.

Authors:  M Otcenásek
Journal:  Mycopathologia       Date:  1992-06       Impact factor: 2.574

Review 5.  Functions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards.

Authors:  J A Washington
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

6.  Failure of fluconazole therapy in Candida krusei fungemia.

Authors:  B L Røder; C Sonnenschein; S H Hartzen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

7.  Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.

Authors:  R M Bannatyne; P C Cheng; I W Fong
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

8.  In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species.

Authors:  A Huang; F Edwards; E M Bernard; D Armstrong; H J Schmitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

9.  Effects of temperature on anti-Candida activities of antifungal antibiotics.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.

Authors:  E W van Etten; N E van de Rhee; K M van Kampen; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.